Mylan Says Cephalon’s IP Win Based On Wrong Construction

Mylan Pharmaceuticals Inc. on Friday urged the Federal Circuit to reverse a district court's ruling that it infringed three patents for Cephalon Inc.'s cancer painkiller Fentora, saying the lower court failed to use the proper claim construction ...read more

  • Tags: